April 2005
Emory holds national conference on HIV vaccine and drug research
ATLANTA--A two-day conference at Emory University will assemble key scientific leaders from the fields of HIV vaccine research and HIV drug development to "bridge the gap" in knowledge about the prevention and treatment of HIV. The conference "Bridging the Sciences: HIV Vaccine Research and Drug Development" will feature scientists and opinion leaders from institutions including the National Institutes of Health, the National Cancer Institute, and national and international academic institutions, as well as leading HIV scientists at Emory University.
The conference will be held May 19 and 20 at the Emory Conference Center Hotel in Atlanta. Session topics will include the science behind vaccine development, HIV drug development and distribution, therapeutic vaccines, and HIV management: options and opportunities, focusing on Africa.
Confirmed faculty include Joep Lange, Center for Poverty-related Communicable Diseases, Academic Medical Center, University of Amsterdam; Douglas Richman, University of California, San Diego/VAMC; Jean-Marie Andrieu, University of Paris; Ronald Desrosiers, New England Primate Research Center; Genoveffa Franchini, National Cancer Institute; Carol Harris, Albert Einstein College of Medicine; Jeffrey Lifson, SAIC Frederick, Inc; John Moore, Cornell University; Gary Nabel, National Institutes of Health; and Kendall Smith, Cornell University. Local faculty will include Walid Heneine, Centers for Disease Control and Prevention; Jeffrey Lennox, Emory University School of Medicine; and Rafi Ahmed, director, Emory Vaccine Center.
The conference is sponsored by Emory University and the Atlanta Veterans Affairs Medical Center. The organizing committee includes Emory HIV researchers Eric Hunter, Georgia Research Alliance Eminent Scholar at the Emory Vaccine Center; Dennis C. Liotta, Emory professor of chemistry; Harriet L. Robinson, professor and director of the Division of Microbiology and Immunology at Yerkes National Primate Research Center and the Emory Vaccine Center; and Raymond F. Schinazi, professor and director, Laboratory of Biochemistry and Pharmacology, Department of Pediatrics, Emory University School of Medicine and senior research career scientist at the Atlanta VA Medical Center.
Academic/government and non-profit attendees are eligible for a discounted conference registration of $100, and students and postdocs may register for a $60 fee. Registration includes breakfast, lunch, dinner and coffee breaks. The deadline for submitting abstracts is Monday, April 25. For more information and online registration, visit the conference website at http://www.informedhorizons.com/bridging2005 or call the Conference Secretariat at 770-997-2484.